Evidence map›Paper›PMID 39446234›Full record

ArticleJournal of general internal medicine2025

Prevalence of Cannabis Use Disorder Among Primary Care Patients with Varying Frequency of Past-Year Cannabis Use.

Gwen T Lapham, Jennifer F Bobb, Casey Luce, Malia M Oliver, Leah K Hamilton, Noorie Hyun, Kevin A Hallgren, Theresa E Matson

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gwen T LaphamKaiser Permanente Washington Health Research Institute, Seattle, USA. gwen.t.lapham@kp.org.ORCID 0000-0001-6965-043X
Jennifer F BobbKaiser Permanente Washington Health Research Institute, Seattle, USA.
Casey LuceKaiser Permanente Washington Health Research Institute, Seattle, USA.
Malia M OliverKaiser Permanente Washington Health Research Institute, Seattle, USA.
Leah K HamiltonKaiser Permanente Washington Health Research Institute, Seattle, USA.
Noorie HyunKaiser Permanente Washington Health Research Institute, Seattle, USA.
Kevin A HallgrenDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
Theresa E MatsonKaiser Permanente Washington Health Research Institute, Seattle, USA.

Funding

Project-002UG1DA040314 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Ingrid A Binswanger, CYNTHIA I CAMPBELL · 2015 to 2026
$34.9M
Intramural Research Program, National Institute on Drug Abuse UG1DA040314NIDA NIH HHS UG1 DA040314
6 · The paper itself

Abstract

backgroundValid, single-item cannabis screens for the frequency of past-year use (SIS-C) can identify patients at risk for cannabis use disorder (CUD); however, the prevalence of CUD for patients who report varying frequencies of use in the clinical setting remains unexplored.

objectiveCompare clinical responses about the frequency of past-year cannabis use to typical use and CUD severity reported on a confidential survey.

participantsAmong adult patients in an integrated health system who completed the SIS-C as part of routine care (3/28/2019-9/12/2019; n = 108,950), 5000 were selected for a confidential survey using stratified random sampling. Among 1688 respondents (34% response rate), 1589 who reported past-year cannabis use on the SIS-C were included. MAIN MEASURES: We compared patients with varying frequency of cannabis use on the SIS-C (< monthly, monthly, weekly, daily) to survey responses on the Composite International Diagnostic Interview Substance Abuse Module for CUD (any and moderate-severe CUD) and cannabis exposure measures (typical use per-week, per-day). Adjusted multinomial (categorical) and logistic regression (binary), weighted for population estimates, estimated the prevalence of outcomes across frequencies. KEY

resultsPatients were predominantly middle-aged (mean = 43.3 years [SD = 16.9]), male (51.8%), white (78.2%), non-Hispanic (94.0%), and commercially insured (68.9%). The prevalence of any and moderate-severe CUD increased with greater frequency of past-year cannabis use reported on the SIS-C (p-values < 0.001) and ranged from 12.7% (6.3-19.2%) and 0.9% (0.0-2.7%) for < monthly to 44.6% (41.4-47.7%) and 20.3% (17.8-22.9%) for daily use, respectively. Greater frequency of use on the SIS-C in the clinical setting corresponded with greater per-week and per-day use on the confidential survey.

conclusionsAmong patients who reported past-year cannabis use as part of routine screening, the prevalence of CUD and other cannabis exposure measures increased with greater frequency of cannabis use, underscoring the utility of brief cannabis screens for identifying patients at risk for CUD.

Indexed as

Marijuana AbuseMarijuana UsePrimary Health CareAdolescentAdultFemaleHumansMaleMiddle AgedPrevalenceSurveys and QuestionnairesYoung Adult

Identifiers

PMID39446234
PMCPMC11968609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.